This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
A5329 is a study for people who are infected with both HIV and the Hepatitis C virus (HCV) and have never taken Hepatitis C...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
